The peptide stimulates both synthesis and breakdown of ECM components while modulating the activity of both metalloproteinases and their inhibitors, creating dynamic matrix remodeling that allows tissue reconstruction without excessive scar formation
A pig pharmacokinetic study reported confusing oral bioavailability values exceeding 100%, which the authors attributed to high data variability
Injection Methods: Subcutaneous (under the skin) for systemic healing and gut support Intramuscular (near the site of injury) for targeted tissue repair Typical Dosing: 250500 micrograms per day, individualized based on your specific needs, goals, and medical history Not a one-size-fits-all approach
Seniors over 75 face the added concern that GLP-1 drugs carry specific risks in older bodies including muscle loss and bone density reduction that require ongoing clinical monitoring
Journal of Metabolic Research , 45(3), 217225
Always consult your peptide suppliers guidelines for specific storage instructions